C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) A61K 31/4745 (2006.01) A61P 5/50 (2006.01)
Patent
CA 2528784
The present invention relates to compounds of formula (I) wherein R1 is as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with DPP-IV, such as diabetes, particularly non- insulin dependent diabetes mellitus, and impaired glucose tolerance.
La présente invention concerne des composés de formule (I), dans laquelle R?1 ¿est tel que défini dans le mémorandum descriptif et dans les revendications, et des sels pharmaceutiquement acceptables desdits composés. Les composés de l'invention sont utiles pour le traitement et/ou la prophylaxie de maladies associées à DPP-IV, telles que le diabète, notamment le diabète non insulino-dépendant, et l'intolérance au glucose.
Boehringer Markus
Kuhn Bernd
Luebbers Thomas
Mattei Patrizio
Narquizian Robert
F.hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Hexahydropyridoisoquinolines as dpp-iv inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hexahydropyridoisoquinolines as dpp-iv inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hexahydropyridoisoquinolines as dpp-iv inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1929836